Dr. Sherryl Shipes, DO

Allen, TX (USA)
Role(s):
Other

STATDOC, Inc. Dba LUXE Medical Spa

Find More Startups Startup
Location: Allen
Industry: Healthcare
Year Founded: 2016
Number Employees: 1-10 people
Business Stage: Growth (profitable)
Entity Type: "S" Corporation
Description: INVESTOR PORTFOLIO CURRENT INFORMATION AS OF JUNE, 2017 Executive Summary The Company Dr. Sherryl Shipes, an emergency medicine doctor at Baylor Surgical Hospital at Las Colinas, started LUXE Medical Spa due to her desire to offer medical injectables to her local community in Allen, Texas.   She opened a boutique spa in February, 2016, and quickly began gathering a following of loyal customers.   Word of mouth and print advertising, as well as Groupon, quickly escalated her business and she soon had over 1300 patients who came for injectables such as Botox and dermal fillers for lip, cheek and face enhancement.   Dr. Shipes invested in the SculpSure device from Cynosure, which is a noninvasive thermal fat melting body sculpting device, as well as the Pelleve/Pellefirm system for wrinkle tightening, fine line correction, cellulite and feminine rejuvenation with Radio Frequency.   She developed a relationship with MERZ Aesthetics, Galderma and Allergan for dermal fillers and botulinum toxin.   She also purchased a Quanta Laser called the EvoForte for IPL Photofacials,  painless hair removal, tattoo removal and skin pigment treatments.   She perfected the European MicroCannula technique for dermal fillers, which minimizes downtime and bruising for facial volumization.   LUXE Medical Spa is now poised to offer a unique spa experience to the local community in a new facility that Dr. Shipes is preparing to build out.   OWNERSHIP AND PERSONNEL AT LUXE The company is structured as an S-corporation, incorporated in the State of Texas. Dr. Sherryl Shipes, DO is the principal and corporate owner.   John Shipes, MA, is the Practice Administrator.   Three RNs are on staff currently. Bookkeeper/Accountant is Victoria Wattigny, CPA. GOALS, OBJECTIVES The objective of LUXE Medical Spa is to offer full body rejuvenation and enhancement techniques that preserve youth, eliminate wrinkles, and in effect, to turn the clock backwards for every patient.   CAPITAL REQUIREMENTS We are in need of investors who wish to own part of our successful corporation. We have commenced the interior buildout of our office space located at Centennial Professional Centre, located at 5285 Independence Parkway, Suite 300, Building A, Frisco, TX 75035.  Estimated time to completion is August, 2017. Ownership background Dr. Sherryl Denise Shipes, DO (shareholder): Since the early 2000's, Dr. Shipes has been a leading physician and advocate in the category of age-reversing aesthetics. She is a personal proponent of nonsurgical techniques including noninvasive laser treatments, dermal fillers and botulinum-related wrinkle treatments for her clientele. She is qualified as an American Board of Family Medicine Board-Certified Medical Doctor and as a Master Aesthetician with the American Academy of Facial Aesthetics to perform expert restorative techniques that are appropriate and proportional.   Dr, Shipes is a diplomate of the American Academy of Cosmetic Surgeons, the American Society of Cosmetic Laser Surgery, and the American Society of Cosmetic Liposuction Surgery. Location analysis The competitive advantage of locating our new medical spa at the corner of Highway 121 and Independence Parkway is that we will be at the crux of four separate communities. This location will be completely accessible and easier to find than our current location in the Salons by JC. The communities we will serve include Frisco to the northwest, McKinney to the northeast, Plano to the southwest and Allen to the southeast, at the new location. Established customers We currently have 1,399 established customers since opening in February, 2016.   MARGIN RATIOS FOR 2017 AND 2018 Operating Profit Margin for Five Months of 2017 24.7% Est Operating Profit Margin for 2017 34.69% Est Operating Profit Margin for 2018 48.72% Net Profit Margin for Five Months of 2017 19.1% Est Net Profit Margin for 2017 14.17% Est Net Profit Margin for 2018 26.64% INVESTOR CONTRIBUTION NUMBER OF SHARES: 100 NUMBER OF SHARES RETAINED BY OWNER: 70 COST PER SHARE AT CURRENT VALUATION: $30,000.00 Based on the EBITDA analysis, which is Earnings before Interest, Taxes, Depreciation & Amortization of all holdings and capital equipment CURRENT NUMBER OF SHARES AVAILABLE: 30